Endocrine and metabolic diseases among colorectal cancer survivors in a population-based cohort.

Makenzie Hawkins, Sean Soisson,Brenna Blackburn,Kerry Rowe,Vikrant Deshmukh,Michael E. Newman,Yuan Wan,Alison Fraser,Ken R. Smith,Cornelia M. Ulrich,Patricia A. Ganz,Niloy Jewel Samadder,Mia Hashibe

Journal of Clinical Oncology（2020）

引用 12|浏览23

暂无评分

摘要

Endocrine and metabolic diseases were statistically significantly higher in CRC survivors throughout the follow up periods of 1-5 years, 5-10 years and greater than 10 years post diagnosis. As the number of CRC survivors increases, understanding the long-term trajectory is critical for improved survivorship care.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要